מה יתרונם של סטארטאפים מקומיים מול מקביליהם הזרים? אילו תעשיות צומחות בלב התקופה הנוכחית ואילו הזדמנויות חבויות בסקטורים החווים את הקשיים הרבים מכל? מדוע יתכן וחברות הזנק ישראליות שנחשבות תמיד לאנדרדוג בקונטקסט העולמי, תהיינה אטרקטיביות יותר להשקעות בתקופה הקרובה? אילו מדינות מתחילות להראות סימנים של חזרה לשגרה בבחינת השקעות ולאילו נראה שייקח זמן ממושך יותר? … Continue Reading
It is important for parties to a transaction who come from other less-litigious business environments to know that U.S. buyers and sellers operate in an environment where litigation is far more frequent, and even a single word can affect the outcome of a dispute. We believe that the example below (just one of many that … Continue Reading
The Greenberg Traurig Tel Aviv office is proud to once again be acknowledged by Chambers Global as a leading firm under the Israel-Corporate/M&A (Desk based Abroad) category. Apart from the group accomplishment, Gary Epstein (Tel-Aviv Managing Shareholder; Co-Chair of the Israel Practice was named Eminent Practitioner under the Israel-Corporate/M&A (Desk based Abroad) category. In addition to … Continue Reading
Introduction With the increasing trend of globalization in the business world, Israeli companies and investors are commonly entering into agreements with U.S.-based entities. One of the most frequently found clauses in U.S. commercial agreements is an anti-assignment provision that prevents either or both of the parties from assigning the agreement to a third party prior … Continue Reading
Earlier this month, the first ever China-Israel Technology, Innovation and Investment Summit, jointly sponsored by the Greenberg Traurig Tel Aviv and Shanghai offices, took place in Beijing. The 3-day event was organized by the Israeli and Chinese governments, together with Infinity Group, an investment firm that has been involved in the China-Israel ecosystem for more … Continue Reading
Name: Ephraim Schmeidler Office: Tel Aviv / New York Member of GT since: 2012 Describe your involvement with the Greenberg Traurig Israel Practice Group: I received my legal training in Israel and practiced law in Israel for five years before moving to the United States 11 years ago. Throughout my legal career in the United … Continue Reading
In a recent deal that has been reported in press outlets around the globe, Israeli pharmaceuticals company Teva has purchased Mexican counterpart Rimsa for US$2.3 billion. Continue Reading. … Continue Reading
Greenberg Traurig’s Tel Aviv office will be hosting a webinar “Doing M&A Deals in Israel” to be presented by Shareholder Joey T. Shabot. The discussion will review common transaction types and structures on cross-border U.S.-Israel deals; employment related matters, including a discussion of non-competes and non-solicits; the importance of obtaining a transaction specific tax ruling … Continue Reading
On March 2, 2015, David Gitlin, a Corporate & Securities shareholder in Greenberg Traurig’s Philadelphia office and a member of the firm’s Israel Practice, presented a guest lecture to a group of leading Israeli business executives at the Manufacturers’ Association of Israel. His lecture focused on negotiation techniques in M&A transactions with an emphasis on … Continue Reading
